American Century Companies Inc. cut its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 0.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 307,797 shares of the company’s stock after selling 1,288 shares during the period. American Century Companies Inc. owned approximately 0.33% of Acadia Healthcare worth $22,159,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also modified their holdings of the company. Durable Capital Partners LP grew its stake in Acadia Healthcare by 30.8% during the fourth quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock worth $159,832,000 after buying an additional 457,687 shares in the last quarter. Alyeska Investment Group L.P. acquired a new stake in Acadia Healthcare during the first quarter worth about $28,751,000. Envestnet Asset Management Inc. grew its stake in Acadia Healthcare by 336.8% during the first quarter. Envestnet Asset Management Inc. now owns 461,951 shares of the company’s stock worth $5,459,000 after buying an additional 356,202 shares in the last quarter. Fred Alger Management LLC grew its stake in Acadia Healthcare by 14.6% during the fourth quarter. Fred Alger Management LLC now owns 2,323,220 shares of the company’s stock worth $191,247,000 after buying an additional 296,704 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in Acadia Healthcare by 923.9% during the fourth quarter. Renaissance Technologies LLC now owns 248,800 shares of the company’s stock worth $20,481,000 after buying an additional 224,500 shares in the last quarter.
Acadia Healthcare Stock Up 0.1 %
Shares of NASDAQ ACHC opened at $77.44 on Thursday. The company has a 50 day simple moving average of $76.54 and a 200 day simple moving average of $73.92. The firm has a market cap of $7.14 billion, a PE ratio of 26.16, a price-to-earnings-growth ratio of 1.94 and a beta of 1.32. Acadia Healthcare Company, Inc. has a 1 year low of $66.87 and a 1 year high of $89.85. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.34 and a quick ratio of 1.34.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the stock. StockNews.com started coverage on shares of Acadia Healthcare in a research note on Thursday, August 17th. They set a “hold” rating on the stock. Credit Suisse Group increased their target price on shares of Acadia Healthcare to $95.00 in a report on Thursday, May 4th. Finally, Royal Bank of Canada increased their target price on shares of Acadia Healthcare from $93.00 to $99.00 and gave the stock an “outperform” rating in a report on Monday, July 31st. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $87.38.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilities, and outpatient clinics.
- Five stocks we like better than Acadia Healthcare
- Why Consider Investing in Nanotechnology Stocks
- Why Ambarella’s 20% Decline is a Strong Signal for New Investment
- Best Stocks Under $5.00
- Why Analysts Love These 2 Car Sales Platforms, And Avoid Dealers
- When to Sell a Stock for Profit or Loss
- A Significant Reversal is in Sight for These 5 Med Tech Companies
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.